Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 7/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29167188 | 1.00 | EPHX1 (0.47) | EPHX1MEN1MAPTKMT2AATM | |
| SCHEMBL10586307 | 0.82 | MAPT (0.44) | EPHX1MEN1MAPTKMT2AATM | |
| SCHEMBL28125848 | 0.82 | FDPS (0.40) | EPHX1MEN1MAPTKMT2AATM | |
| SCHEMBL16860620 | 0.82 | MEN1 (0.56) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL10518797 | 0.82 | FDPS (0.39) | EPHX1MEN1MAPTKMT2AATM | |
| SCHEMBL9643600 | 0.81 | MEN1 (0.42) | EPHX1MEN1MAPTKMT2AATM | |
| SCHEMBL25173893 | 0.79 | MEN1 (0.47) | EPHX1MEN1MAPTKMT2AATM | |
| SCHEMBL486917 | 0.79 | MEN1 (0.47) | EPHX1MEN1MAPTKMT2AATM | |
| SCHEMBL18612495 | 0.79 | MAPT (0.47) | EPHX1MEN1MAPTKMT2AATM | |
| SCHEMBL14445397 | 0.79 | MAPT (0.47) | EPHX1MEN1MAPTKMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5180761-A | Solid lubricants treated with titanates or silane compounds | NATIONAL SCIENCE COUNCIL (TW) | 1993-01-19 | — | — | US | claimed |
| US-20250179243-A1 | MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM | TOSOH CORPORATION (JP) | 2025-06-05 | — | — | US | disclosed |
| EP-4455128-A1 | MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM | Tosoh Corporation (JP) | 2024-10-30 | — | — | EP | disclosed |
| CN-118434793-A | Main chain polymer, optical film, method for producing same, and multilayer film | 东曹株式会社 | 2024-08-02 | — | — | CN | disclosed |
| WO-2023120638-A1 | MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM | 東ソー株式会社 | 2023-06-29 | — | — | WO | disclosed |
| EP-3087155-A1 | CONTROL OF SUSTAINED CASING PRESSURE IN WELLBORE ANNULI | Albemarle Corporation (US) | 2016-11-02 | — | — | EP | disclosed |
| US-20160289527-A1 | CONTROL OF SUSTAINED CASING PRESSURE IN WELLBORE ANNULI | ALBEMARLE CORP (US) | 2016-10-06 | — | — | US | disclosed |
| WO-2015100004-A1 | CONTROL OF SUSTAINED CASING PRESSURE IN WELLBORE ANNULI | ALBEMARLE CORPORATION (US) | 2015-07-02 | — | — | WO | disclosed |
| US-5180761-A | Solid lubricants treated with titanates or silane compounds | NATIONAL SCIENCE COUNCIL (TW) | 1993-01-19 | — | — | US | disclosed |
| US-3984362-A | Reinforcing polymers with laundered amorphous lignin | CANADIAN PATENTS AND DEVELOPMENT LIMITED (CA) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250179243-A1 | MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM | C9, RNF4, F12 | EPHX1 3615/4885MEN1 3399/4885MAPT 452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.